A Call to Arms: Quest for a Cryptococcal Vaccine

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861 · see citing works

Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L. A. B., Ifrim, D. C., Saeed, S., Jacobs, C., van Loenhout, J., de Jong, D., Stunnenberg, H. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202870109 · Cited by 1,728 · see citing works

Trained Immunity: A Memory for Innate Host Defense

Netea, M. G., Quintin, J., & van der Meer, J. W. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.04.006 · Cited by 1,697 · see citing works

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570 · see citing works

Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes

Quintin, J., Saeed, S., Martens, J. H. A., Giamarellos-Bourboulis, E. J., Ifrim, D. C., Logie, C., Jacobs, L., Jansen, T., Kullberg, B.-J., Wijmenga, C., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.006 · Cited by 1,289 · see citing works

Practice Guidelines for the Management of Cryptococcal Disease

Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,101 · see citing works

Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T. M., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 808 · see citing works

Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi

Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · see citing works

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis

Kwon-Chung, K. J., Fraser, J. A., Doering, T. L., Wang, Z. A., Janbon, G., Idnurm, A., & Bahn, Y.-S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019760 · Cited by 531 · see citing works

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

Giaccone, G., Punt, C. J. A., Ando, Y., Ruijter, R., Nishi, N., Peters, M. E. W. J., Blomberg, B. M. E. V., Scheper, R. J., van der Vliet, H. J., van den Eertwegh, A. J. M., et al. (2002) · PubMed · Cited by 506 · see citing works

EPIDEMIOLOGIC DIFFERENCES BETWEEN THE TWO VARIETIES OF CRYPTOCOCCUS NEOFORMANS1

Kwon-Chung, K. J., & Bennett, J. E. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113861 · Cited by 474 · see citing works

Chapter 4 The Capsule of the Fungal Pathogen Cryptococcus neoformans

Zaragoza, Ó., Rodrigues, M. L., Jesus, M. D., Frasés, S., Dadachova, E., & Casadevall, A. (2009) · Advances in applied microbiology · doi:10.1016/s0065-2164(09)01204-0 · Cited by 458 · see citing works

Cryptococcosis

Chayakulkeeree, M., & Perfect, J. R. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.001 · Cited by 396 · see citing works

Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin

Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362 · see citing works

Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome

Husain, S., Wagener, M. M., & Singh, N. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010302 · Cited by 328 · see citing works

Cryptococcus neoformans Infection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome

Husain, S., Wagener, M. M., & Singh, N. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.017302 · Cited by 313 · see citing works

Characterization of a Murine Monoclonal Antibody to <i>Cryptococcus neoformans</i> Polysaccharide That Is a Candidate for Human Therapeutic Studies

Casadevall, A., Cleare, W., Feldmesser, M., Glatman-Freedman, A., Goldman, D. L., Kozel, T. R., Lendvai, N., Mukherjee, J., Pirofski, L.-A., Rivera, J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1437 · Cited by 298 · see citing works

Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms

Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291 · see citing works

Chronic cryptococcal meningitis: a new experimental model in rabbits.

Perfect, J. R., Lang, S. D. R., & Durack, D. T. (1980) · PubMed · Cited by 283 · see citing works

Cryptococcal Meningitis and AIDS

Powderly, W. G. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.5.837 · Cited by 278 · see citing works

Spread of Cryptococcus gattii into Pacific Northwest Region of the United States

Datta, K., Bartlett, K. H., Baer, R. J., Byrnes, E. J., Galanis, E., Heitman, J., Hoang, L., Leslie, M. J., MacDougall, L., Magill, S. S., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1508.081384 · Cited by 271 · see citing works

Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.

Huffnagle, G. B., Yates, J. L., & Lipscomb, M. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.793 · Cited by 265 · see citing works

Epidemiology ofCryptococcus gattii, British Columbia, Canada, 1999–2007

Galanis, E., MacDougall, L., Kidd, S. E., Morshed, M., & the British Columbia Cryptococcus gattii Working Group (2010) · Emerging infectious diseases · doi:10.3201/eid1602.090900 · Cited by 262 · see citing works

An Immune Reconstitution Syndrome-Like Illness Associated withCryptococcus neoformans Infection in Organ Transplant Recipients

Singh, N. R., Lortholary, O., Alexander, B. D., Gupta, K. L., John, G. T., Pursell, K. J., Munoz, P., Klintmalm, G. B. G., Stosor, V., Busto, R. D., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430606 · Cited by 249 · see citing works

Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis

Larsen, R. A., Pappas, P. G., Perfect, J., Aberg, J. A., Casadevall, A., Cloud, G. A., James, R., Filler, S., & Dismukes, W. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.952-958.2005 · Cited by 236 · see citing works

Cryptococcus neoformans Strains and Infection in Apparently Immunocompetent Patients, China

Chen, J., Varma, A., Diaz, M. R., Litvintseva, A. P., Wollenberg, K. R., & Kwon-Chung, K. J. (2008) · Emerging infectious diseases · doi:10.3201/eid1405.071312 · Cited by 231 · see citing works

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus gattii in Otherwise Immunocompetent Patients

Saijo, T., Chen, J., Chen, S. C.-A., Rosen, L. B., Yi, J., Sorrell, T. C., Bennett, J. E., Holland, S. M., Browne, S., & Kwon-Chung, K. J. (2014) · mBio · doi:10.1128/mbio.00912-14 · Cited by 226 · see citing works

Immune reconstitution syndrome associated with opportunistic mycoses

Singh, N., & Perfect, J. R. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70085-3 · Cited by 224 · see citing works

Immunocompromised Hosts: Cryptococcosis in Solid Organ Transplant Recipients: Current State of the Science

Singh, N., Dromer, F., Perfect, J. R., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/592690 · Cited by 220 · see citing works

Cryptococcal infections in non-HIV-infected patients.

Pappas, P. G. (2013) · PubMed · Cited by 208 · see citing works

The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection

Huffnagle, G. B., Lipscomb, M. F., Lovchik, J. A., Hoag, K. A., & Street, N. E. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.1.35 · Cited by 206 · see citing works

Vaccine development strategies for improving immunization: the role of modern immunology

Levine, M. M., & Sztein, M. B. (2004) · Nature Immunology · doi:10.1038/ni0504-460 · Cited by 198 · see citing works

Epidemiology of HIV-associated cryptococcosis in France (1985–2001)

Dromer, F., Mathoulin‐Pélissier, S., Fontanet, A. L., Ronin, O., Dupont, B., & Lortholary, O. (2004) · AIDS · doi:10.1097/00002030-200402200-00024 · Cited by 193 · see citing works

Protection against Cryptococcosis by Using a Murine Gamma Interferon-Producing <i>Cryptococcus neoformans</i> Strain

Wormley, F. L., Perfect, J. R., Steele, C., & Cox, G. M. (2007) · Infection and Immunity · doi:10.1128/iai.00274-06 · Cited by 187 · see citing works

Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity

Devi, S. J., Schneerson, R., Egan, W., Ulrich, T., Bryla, D., Robbins, J. B., & Bennett, J. E. (1991) · Infection and Immunity · doi:10.1128/iai.59.10.3700-3707.1991 · Cited by 184 · see citing works

Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases

Casadevall, A., & Pirofski, L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.004 · Cited by 180 · see citing works

Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries

Loyse, A., Thangaraj, H. S., Easterbrook, P., Ford, N. P., Roy, M., Chiller, T. M., Govender, N. P., Harrison, T. S., & Bicanic, T. A. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70078-1 · Cited by 178 · see citing works

Invasive Fungal Infections in Solid Organ Transplant Recipients

Shoham, S., & Marr, K. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.28 · Cited by 176 · see citing works

HIV and co‐infections

Chang, C. C., Crane, M., Zhou, J., Mina, M., Post, J. J., Cameron, B., Lloyd, A. R., Jaworowski, A., French, M. A., & Lewin, S. R. (2013) · Immunological Reviews · doi:10.1111/imr.12063 · Cited by 169 · see citing works

An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo

Rachini, A., Pietrella, D., Lupo, P., Torosantucci, A., Chiani, P., Bromuro, C., Proietti, C., Bistoni, F., Cassone, A., & Vecchiarelli, A. (2007) · Infection and Immunity · doi:10.1128/iai.00278-07 · Cited by 165 · see citing works

Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.

Mody, C. H., Lipscomb, M. F., Street, N. E., & Toews, G. B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.4.1472 · Cited by 164 · see citing works

The molecular basis for the immunogenicity ofCryptococcus neoformansmannoproteins

Levitz, S. M., & Specht, C. A. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00071.x · Cited by 154 · see citing works

Prevalence of Clinical Isolates ofCryptococcus gattiiSerotype C among Patients with AIDS in Sub‐Saharan Africa

Litvintseva, A. P., Thakur, R., Reller, L. B., & Mitchell, T. G. (2005) · The Journal of Infectious Diseases · doi:10.1086/432486 · Cited by 153 · see citing works

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model

Devi, S. J. (1996) · Vaccine · doi:10.1016/0264-410x(95)00256-z · Cited by 148 · see citing works

Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans

Levitz, S. M., Nong, S.-H., Mansour, M. K., Huang, C., & Specht, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181331398 · Cited by 146 · see citing works

Autochthonous and DormantCryptococcus gattiiInfections in Europe

Hagen, F., Colom, M. F., Swinne, D., Tintelnot, K., Iatta, R., Montagna, M. T., Torres-Rodrı́guez, J. M., Cogliati, M., Velegraki, A., Burggraaf, A., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1810.120068 · Cited by 142 · see citing works

T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice

Huffnagle, G. B., Yates, J. L., & Lipscomb, M. F. (1991) · Infection and Immunity · doi:10.1128/iai.59.4.1423-1433.1991 · Cited by 141 · see citing works

Passive Immunization with Melanin-Binding Monoclonal Antibodies Prolongs Survival of Mice with Lethal Cryptococcus neoformans Infection

Rosas, Á. L., Nosanchuk, J. D., & Casadevall, A. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.3410-3412.2001 · Cited by 141 · see citing works

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host

Pirofski, L., & Casadevall, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.1 · Cited by 138 · see citing works

Molecular mechanisms of cryptococcal meningitis

Liu, T.-B., Perlin, D. S., & Xue, C. (2012) · Virulence · doi:10.4161/viru.18685 · Cited by 131 · see citing works

Hsp90 orchestrates stress response signaling governing fungal drug resistance

Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000471 · Cited by 130 · see citing works

A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease

Chau, T. T., Mai, N. H., Phu, N. H., Nghia, H. D. T., Chuong, L. V., Sinh, D. X., Duong, V. A., Diep, P. T., Campbell, J. I., Baker, S. G., et al. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-199 · Cited by 127 · see citing works

Cell Wall Chitosan Is Necessary for Virulence in the Opportunistic Pathogen Cryptococcus neoformans

Baker, L. G., Specht, C. A., & Lodge, J. K. (2011) · Eukaryotic Cell · doi:10.1128/ec.05138-11 · Cited by 125 · see citing works

Early Cytokine Production in Pulmonary Cryptococcus Neoformans Infections Distinguishes Susceptible and Resistant Mice

Hoag, K. A., Street, N. E., Huffnagle, G. B., & Lipscomb, M. F. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.4.7546779 · Cited by 121 · see citing works

Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans

Upadhya, R., Lam, W. C., Maybruck, B. T., Specht, C. A., Levitz, S. M., & Lodge, J. K. (2016) · mBio · doi:10.1128/mbio.00547-16 · Cited by 121 · see citing works

Emergence of Cryptococcus gattii—Pacific Northwest, 2004-2010

(2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.11.002 · Cited by 119 · see citing works

Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii

Chen, S. C.-A., Korman, T. M., Slavin, M. A., Marriott, D. J. E., Byth, K., Bak, N., Currie, B. J., Hajkowicz, K. M., Heath, C. H., Kidd, S. E., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit341 · Cited by 116 · see citing works

Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265

Sorrell, T. C., Juillard, P.-G., Djordjevic, J. T., Kaufman-Francis, K., Dietmann, A., Milonig, A., Combes, V., & Grau, G. E. R. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2015.08.017 · Cited by 113 · see citing works

A Cryptococcal Capsular Polysaccharide Mimotope Prolongs the Survival of Mice with Cryptococcus neoformans Infection

Fleuridor, R., Lees, A., & Pirofski, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1087 · Cited by 112 · see citing works

Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study

D, S. S. M., Filler, S. G., Chetchotisakd, P., Pappas, P. G., Nolen, T. L., Manosuthi, W., Anekthananon, T., Morris, M. I., Supparatpinyo, K., Kopetskie, H., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605497 · Cited by 109 · see citing works

Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens

Murphy, J. W., Mosley, R. L., Cherniak, R., Reyes, G. H., Kozel, T. R., & Reiss, E. (1988) · Infection and Immunity · doi:10.1128/iai.56.2.424-431.1988 · Cited by 106 · see citing works

Mannoproteins from Cryptococcus neoformans Promote Dendritic Cell Maturation and Activation

Pietrella, D., Corbucci, C., Perito, S., Bistoni, G., & Vecchiarelli, A. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.820-827.2005 · Cited by 102 · see citing works

Purification and Characterization of a Second Immunoreactive Mannoprotein fromCryptococcus neoformansThat Stimulates T-Cell Responses

Huang, C., Nong, S.-H., Mansour, M. K., Specht, C. A., & Levitz, S. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5485-5493.2002 · Cited by 100 · see citing works

Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis

Wozniak, K. L., Ravi, S., Macias, S., Young, M. L., Olszewski, M. A., Steele, C., & Wormley, F. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006854 · Cited by 99 · see citing works

Generation of Antifungal Effector CD8+ T Cells in the Absence of CD4+ T Cells during Cryptococcus neoformans Infection

Lindell, D. M., Moore, T. A., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7920 · Cited by 98 · see citing works

Evaluation of trained immunity by β‐1, 3 ( d )‐glucan on murine monocytes in vitro and duration of response in vivo

García-Valtanen, P., Guzman‐Genuino, R. M., Williams, D. L., Hayball, J. D., & Diener, K. R. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.13 · Cited by 98 · see citing works

STAT1 Signaling within Macrophages Is Required for Antifungal Activity against Cryptococcus neoformans

Wager, C. M. L., Hole, C. R., Wozniak, K. L., Olszewski, M. A., Mueller, M., & Wormley, F. L. (2015) · Infection and Immunity · doi:10.1128/iai.00935-15 · Cited by 95 · see citing works

Mechanisms of Cryptococcal Virulence and Persistence

Olszewski, M. A., Zhang, Y., & Huffnagle, G. B. (2010) · Future Microbiology · doi:10.2217/fmb.10.93 · Cited by 94 · see citing works

Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development

Rella, A., Mor, V., Farnoud, A. M., Singh, A., Shamseddine, A. A., Ivanova, E., Carpino, N., Montagna, M. T., Luberto, C., & Poeta, M. D. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00836 · Cited by 85 · see citing works

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles ContainingCryptococcusAlkaline Extracts

Specht, C. A., Lee, C. K., Huang, H., Tipper, D. J., Shen, Z. T., Lodge, J. K., Leszyk, J., Ostroff, G. R., & Levitz, S. M. (2015) · mBio · doi:10.1128/mbio.01905-15 · Cited by 85 · see citing works

First Reported Case of Cryptococcus gattii in the Southeastern USA: Implications for Travel-Associated Acquisition of an Emerging Pathogen

Byrnes, E. J., Li, W., Lewit, Y., Perfect, J. R., Carter, D. A., Cox, G. M., & Heitman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005851 · Cited by 80 · see citing works

Development of Protective Inflammation and Cell-Mediated Immunity against Cryptococcus neoformans after Exposure to Hyphal Mutants

Zhai, B., Wozniak, K. L., Masso-Silva, J. A., Upadhyay, S., Hole, C. R., Rivera, A., Wormley, F. L., & Lin, X. (2015) · mBio · doi:10.1128/mbio.01433-15 · Cited by 79 · see citing works

Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against Lethal Cryptococcus neoformans Infection

Rodrigues, M. L., Li, S., Barreto‐Bergter, E., Nimrichter, L., Farias, S. E., Rodrigues, E. G., Travassos, L. R., & Nosanchuk, J. D. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00202-07 · Cited by 77 · see citing works

Protective Immunity against Experimental Pulmonary Cryptococcosis in T Cell-Depleted Mice

Wozniak, K. L., Young, M. L., & Wormley, F. L. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00036-11 · Cited by 72 · see citing works

Requirement for CD4+T Lymphocytes in Host Resistance againstCryptococcus neoformansin the Central Nervous System of Immunized Mice

Buchanan, K. L., & Doyle, H. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.456-462.2000 · Cited by 72 · see citing works

Protective Efficacy of Antigenic Fractions in Mouse Models of Cryptococcosis

Mansour, M. K., Yauch, L. E., Rottman, J. B., & Levitz, S. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1746-1754.2004 · Cited by 70 · see citing works

Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody

Zhang, H., Zhong, Z., & Pirofski, L. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1158-1164.1997 · Cited by 68 · see citing works

Genotypes Coding for Mannose-Binding Lectin Deficiency Correlated With Cryptococcal Meningitis in HIV-Uninfected Chinese Patients

Ou, X., Wu, J., Zhu, L., Guan, M., Xu, B., Hu, X., Wang, L., & Weng, X. H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir152 · Cited by 66 · see citing works

Contribution of Glycosylation to T Cell Responses Stimulated by RecombinantCryptococcus neoformansMannoprotein

Specht, C. A., Nong, S., Dan, J. M., Lee, C. K., & Levitz, S. M. (2007) · The Journal of Infectious Diseases · doi:10.1086/520536 · Cited by 63 · see citing works

Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides

Dan, J. M., Wang, J. P., Lee, C. K., & Levitz, S. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002046 · Cited by 63 · see citing works

A Pilot Study of the Discontinuation of Antifungal Therapy for Disseminated Cryptococcal Disease in Patients with Acquired Immunodeficiency Syndrome, following Immunologic Response to Antiretroviral Therapy

Aberg, J. A., Price, R. W., Heeren, D. M., & Bredt, B. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/339680 · Cited by 62 · see citing works

Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease

Rohatgi, S., Gohil, S. K., Kuniholm, M. H., Schultz, H., Dufaud, C. R., Armour, K. L., Badri, S. M., Mailliard, R. B., & Pirofski, L. (2013) · mBio · doi:10.1128/mbio.00573-13 · Cited by 62 · see citing works

Emergence of Cryptococcus gattii-- Pacific Northwest, 2004-2010.

(2010) · PubMed · Cited by 61 · see citing works

Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components againstCryptococcus neoformans

Murphy, J. W., Schafer, F. B., Casadevall, A., & Adesina, A. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2632-2639.1998 · Cited by 59 · see citing works

Association of Fcγ Receptor IIB Polymorphism with Cryptococcal Meningitis in HIV-Uninfected Chinese Patients

Hu, X., Wu, J., Zhu, L., Wang, X., Xu, B., Wang, R., Ou, X., & Weng, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042439 · Cited by 57 · see citing works

Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis

Kakeya, H., Udono, H., Maesaki, S., Sasaki, E., Kawamura, S., HOSSAIN, M. A., Yamamoto, Y., Sawai, T., Fukuda, M., Mitsutake, K., et al. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00821.x · Cited by 56 · see citing works

Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche

Datta, K., Bartlett, K. H., & Marr, K. A. (2009) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2009/176532 · Cited by 56 · see citing works

Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011

Lizarazo, J., Escandón, P., Agudelo, C. I., Firacative, C., Meyer, W., & Castañeda, E. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003272 · Cited by 54 · see citing works

A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis

Kakeya, H., Udono, H., Ikuno, N., Yamamoto, Y., Mitsutake, K., Miyazaki, T., Tomono, K., Koga, H., Tashiro, T., Nakayama, E., et al. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1653-1658.1997 · Cited by 54 · see citing works

Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan

Datta, K., Lees, A., & Pirofski, L. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00130-08 · Cited by 53 · see citing works

Potent Inhibition of Neutrophil Migration by Cryptococcal Mannoprotein-4-Induced Desensitization

Coenjaerts, F. E. J., Walenkamp, A., Mwinzi, P. N. M., Scharringa, J., Dekker, H. A. T., van Strijp, J. A. G., Cherniak, R., & Hoepelman, A. I. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3988 · Cited by 52 · see citing works

Identification and Cloning of a Cryptococcal Deacetylase That Produces Protective Immune Responses

Biondo, C., Beninati, C., Delfino, D., Oggioni, M. R., Mancuso, G., Midiri, A., Bombaci, M., Tomaselli, G., & Teti, G. (2002) · Infection and Immunity · doi:10.1128/iai.70.5.2383-2391.2002 · Cited by 52 · see citing works

Characterization of Two Novel Cryptococcal Mannoproteins Recognized by Immune Sera

Biondo, C., Messina, L., Bombaci, M., Mancuso, G., Midiri, A., Beninati, C., Cusumano, V., Gerace, E., Papasergi, S., & Teti, G. (2005) · Infection and Immunity · doi:10.1128/iai.73.11.7348-7355.2005 · Cited by 50 · see citing works

Vaccine-Mediated Immune Responses to Experimental Pulmonary Cryptococcus gattii Infection in Mice

Chaturvedi, A. K., Hameed, R. S., Wozniak, K. L., Hole, C. R., Wager, C. M. L., Weintraub, S. T., Lopez-Ribot, J. L., & Wormley, F. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104316 · Cited by 45 · see citing works

Approaches to Antifungal Therapies and Their Effectiveness among Patients with Cryptococcosis

Bratton, E. W., Husseini, N. E., Chastain, C. A., Lee, M. S., Poole, C., Stürmer‎, T., Weber, D. J., Juliano, J. J., & Perfect, J. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01800-12 · Cited by 42 · see citing works

Hyporesponsiveness to Natural Killer T-Cell Ligand α-Galactosylceramide in Cancer-Bearing State Mediated by CD11b+ Gr-1+ Cells Producing Nitric Oxide

Yanagisawa, K., Exley, M. A., Jiang, X., Ohkochi, N., Taniguchi, M., & Seino, K.-I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0944 · Cited by 41 · see citing works

Fatal Disseminated Cryptococcus gattii Infection in New Mexico

Walraven, C. J., Gerstein, W. H., Hardison, S. E., Wormley, F. L., Lockhart, S. R., Harris, J. R., Fothergill, A. W., Wickes, B. L., Gober-Wilcox, J., Massie, L. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028625 · Cited by 41 · see citing works

A proteomic‐based approach for the identification of immunodominant Cryptococcus neoformans proteins

Young, M. L., Macias, S., Thomas, D. P., & Wormley, F. L. (2009) · PROTEOMICS · doi:10.1002/pmic.200800713 · Cited by 41 · see citing works

Cryptococcus gattii Infection in Healthy Hosts: A Sentinel for Subclinical Immunodeficiency?

Marr, K. A., Datta, K., Pirofski, L., & Barnes, R. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir756 · Cited by 40 · see citing works

Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans

Fromtling, R. A., Blackstock, R., Hall, N. K., & Bulmer, G. S. (1979) · Mycopathologia · doi:10.1007/bf00578527 · Cited by 39 · see citing works

Vaccine and Immunotherapeutic Approaches for the Prevention of Cryptococcosis: Lessons Learned from Animal Models

Hole, C. R., & Wormley, F. L. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00291 · Cited by 35 · see citing works

Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants

Kim, S., Lalani, S., Parekh, V. V., Wu, L., & Kaer, L. V. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.10.1519 · Cited by 34 · see citing works

Sterylglucoside Catabolism in Cryptococcus neoformans with Endoglycoceramidase-related Protein 2 (EGCrP2), the First Steryl-β-glucosidase Identified in Fungi

Watanabe, T., Ito, T., Goda, H. M., Ishibashi, Y., Miyamoto, T., Ikeda, K., Taguchi, R., Okino, N., & Ito, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616300 · Cited by 34 · see citing works

Identification and characterization of C ryptococcus neoformans protein fractions that induce protective immune responses

Chaturvedi, A. K., Weintraub, S. T., Lopez-Ribot, J. L., & Wormley, F. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201300213 · Cited by 30 · see citing works

The Cryptococcus neoformans Gene DHA1 Encodes an Antigen That Elicits a Delayed-Type Hypersensitivity Reaction in Immune Mice

Mandel, M. A., Grace, G. G., Orsborn, K. I., Schafer, F. B., Murphy, J. W., Orbach, M. J., & Galgiani, J. N. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6196-6201.2000 · Cited by 30 · see citing works

TheIn VivoResponse of Invariant Natural Killer T Cells to Glycolipid Antigens

Parekh, V. V., Lalani, S., & Kaer, L. V. (2007) · International Reviews of Immunology · doi:10.1080/08830180601070179 · Cited by 29 · see citing works

The Cell Wall and Membrane ofCryptococcus neoformansPossess a Mitogen for Human T Lymphocytes

Mody, C. H., Wood, C. J., Syme, R., & Spurrell, J. C. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.936-941.1999 · Cited by 29 · see citing works

Molecular and Idiotypic Analyses of the Antibody Response toCryptococcus neoformansGlucuronoxylomannan-Protein Conjugate Vaccine in Autoimmune and Nonautoimmune Mice

Nussbaum, G., Anandasabapathy, S., Mukherjee, J., Fan, M., Casadevall, A., & Scharff, M. D. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4469-4476.1999 · Cited by 28 · see citing works

Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis

Mor, V., Farnoud, A. M., Singh, A., Rella, A., Tanno, H., Ishii, K., Kawakami, K., Sato, T., & Poeta, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153853 · Cited by 28 · see citing works

Is Cryptococcus gattii a Primary Pathogen?

Kwon-Chung, K. J., & Saijo, T. (2015) · Journal of Fungi · doi:10.3390/jof1020154 · Cited by 27 · see citing works

Cryptococcus gattii Genotype VGI Infection in New England

McCulloh, R. J., Phillips, R., Perfect, J. R., Byrnes, E. J., Heitman, J., & Dufort, E. M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822d14fd · Cited by 26 · see citing works

Induction of T Helper Type 1 Responses by a Polysaccharide Deacetylase fromCryptococcus neoformans

Biondo, C., Beninati, C., Bombaci, M., Messina, L., Mancuso, G., Midiri, A., Galbo, R., & Teti, G. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5412-5417.2003 · Cited by 24 · see citing works

Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain

Wormley, F. L., Cox, G. M., & Perfect, J. R. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.12.007 · Cited by 23 · see citing works

Immunization of mice with stable, acapsular, yeastlike mutants ofCryptococcus neoformans

Fromtling, R. A., Kaplan, A. M., & Shadomy, H. J. (1983) · Medical Mycology · doi:10.1080/00362178385380181 · Cited by 18 · see citing works

Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan

Maitta, R. W. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.03.060 · Cited by 15 · see citing works

Susceptibility to Progressive Cryptococcus neoformans Pulmonary Infection Is Regulated by Loci on Mouse Chromosomes 1 and 9

Carroll, S. F., Lafferty, E. I., Flaczyk, A., Fujiwara, T. M., Homer, R., Morgan, K., Loredo‐Osti, J., & Qureshi, S. T. (2012) · Infection and Immunity · doi:10.1128/iai.00417-12 · Cited by 15 · see citing works

The Cnes2 Locus on Mouse Chromosome 17 Regulates Host Defense against Cryptococcal Infection through Pleiotropic Effects on Host Immunity

Shourian, M., Flaczyk, A., Angers, I., Mindt, B., Fritz, J. H., & Qureshi, S. (2015) · Infection and Immunity · doi:10.1128/iai.00697-15 · Cited by 10 · see citing works

Treatment strategies for cryptococcal infection: challenges, advances and future outlook

Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363 · see citing works

Induction of memory-like dendritic cell responses in vivo

Hole, C. R., Wager, C. M. L., Castro-Lopez, N., Campuzano, A., Cai, H., Wozniak, K. L., Wang, Y., & Wormley, F. L. (2019) · Nature Communications · doi:10.1038/s41467-019-10486-5 · Cited by 196 · see citing works

New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159 · see citing works

Vaccines for human fungal diseases: close but still a long way to go

Oliveira, L. V. N., Wang, R., Specht, C. A., & Levitz, S. M. (2021) · npj Vaccines · doi:10.1038/s41541-021-00294-8 · Cited by 135 · see citing works

Cryptococcus extracellular vesicles properties and their use as vaccine platforms

Rizzo, J., Wong, S. S. W., Gazi, A. D., Moyrand, F., Chaze, T., Commère, P., Novault, S., Matondo, M., Pehau‐Arnaudet, G., Reis, F. C. G., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12129 · Cited by 120 · see citing works

Life Cycle ofCryptococcus neoformans

Zhao, Y., Lin, J., Fan, Y., & Lin, X. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-120210 · Cited by 102 · see citing works

IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans

Wager, C. M. L., Hole, C. R., Campuzano, A., Castro-Lopez, N., Cai, H., Dyke, M. C. C. V., Wozniak, K. L., Wang, Y., & Wormley, F. L. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007358 · Cited by 75 · see citing works

Mechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans

Denham, S., & Brown, J. (2018) · Journal of Fungi · doi:10.3390/jof4010025 · Cited by 67 · see citing works

Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response

Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50 · see citing works

Cryptococcus neoformans: Sex, morphogenesis, and virulence

Zhao, Y., & Lin, X. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104731 · Cited by 51 · see citing works

A synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes

Guazzelli, L., Crawford, C. J., Ulc, R., Bowen, A. D., McCabe, O., Jedlicka, A. J., Wear, M. P., Casadevall, A., & Oscarson, S. (2020) · Chemical Science · doi:10.1039/d0sc01249a · Cited by 45 · see citing works

Vaccines and Protective Immune Memory against Cryptococcosis

Ueno, K., Yanagihara, N., Shimizu, K., & Miyazaki, Y. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00841 · Cited by 34 · see citing works

Immunoprotection against Cryptococcosis Offered by Znf2 Depends on Capsule and the Hyphal Morphology

Lin, J., Pham, T., Hipsher, K., Glueck, N. K., Fan, Y., & Lin, X. (2022) · mBio · doi:10.1128/mbio.02785-21 · Cited by 32 · see citing works

Harnessing the Immune Response to Fungal Pathogens for Vaccine Development

Rivera, A., Lodge, J. K., & Xue, C. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-111511 · Cited by 35 · see citing works

Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection

Normile, T. G., Rella, A., & Poeta, M. D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.739027 · Cited by 30 · see citing works

Limited Role of Mincle in the Host Defense against Infection with Cryptococcus deneoformans

Sato, Y., Sato, K., Yamamoto, H., Kasamatsu, J., Miyasaka, T., Tanno, D., Miyahara, A., Kagesawa, T., Oniyama, A., Kawamura, K., et al. (2020) · Infection and Immunity · doi:10.1128/iai.00400-20 · Cited by 22 · see citing works

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1

Normile, T. G., & Poeta, M. D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868523 · Cited by 22 · see citing works

Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling

Normile, T. G., Chu, T. H., Sheridan, B. S., & Poeta, M. D. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00570-3 · Cited by 22 · see citing works

iNOS/Arginase-1 expression in the pulmonary tissue over time during Cryptococcus gattii infection

Brito, P. K. M. O., Rezende, C. P., Almeida, F. B. D. R., Roque‐Barreira, M. C., & da Silva, T. A. (2019) · Innate Immunity · doi:10.1177/1753425919869436 · Cited by 22 · see citing works

Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe

Crawford, C. J., Cordero, R. J. B., Guazzelli, L., Wear, M. P., Bowen, A. D., Oscarson, S., & Casadevall, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012251 · Cited by 22 · see citing works

Characteristics and potential clinical applications of the extracellular vesicles of human pathogenic Fungi

Ullah, A., Huang, Y., Zhao, K., Hua, Y., Ullah, S., Rahman, M. U., Wang, J., Wang, Q., Hu, X., & Zheng, L. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02945-3 · Cited by 23 · see citing works

The remarkable complexity of the brain microbiome in health and diseasePreprint

Hu, X., McKenzie, C.-A., Smith, C., Haas, J., & Lathe, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.06.527297 · Cited by 20 · see citing works

Semisynthetic Glycoconjugate Vaccine Candidates against Cryptococcus neoformans

Crawford, C. J., Liporagi-Lopes, L., Coelho, C., dos Santos, S. R., Nicola, A. M., Wear, M. P., Vij, R., Oscarson, S., & Casadevall, A. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00094 · Cited by 17 · see citing works

Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen

Crawford, C. J., Guazzelli, L., McConnell, S. A., McCabe, O., d’Errico, C., Greengo, S. D., Wear, M. P., Jedlicka, A., Casadevall, A., & Oscarson, S. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00447 · Cited by 15 · see citing works

PAMPs and Host Immune Response in Cryptococcal Infection

Sato, K., & Kawakami, K. (2022) · Medical Mycology Journal · doi:10.3314/mmj.22.005 · Cited by 14 · see citing works

Vaccination with a ZNF2 oe Strain of Cryptococcus Provides Long-Lasting Protection against Cryptococcosis and Is Effective in Immunocompromised Hosts

Pham, T., Li, Y., Watford, W. T., & Lin, X. (2023) · Infection and Immunity · doi:10.1128/iai.00198-23 · Cited by 14 · see citing works

Differential Effects of Linkers on the Activity of Amphiphilic Tobramycin Antifungals

Fosso, M. Y., Shrestha, S. K., Chandrika, N. T., Dennis, E. K., Green, K. D., & Garneau‐Tsodikova, S. (2018) · Molecules · doi:10.3390/molecules23040899 · Cited by 14 · see citing works

The Overlooked Glycan Components of the Cryptococcus Capsule

Fonseca, F. L., Reis, F. C. G., Sena, B. A. G., Jozefowicz, L. J., Kmetzsch, L., & Rodrigues, M. L. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_140 · Cited by 14 · see citing works

Advances in fungal vaccine development: Progress in the face of emerging challenges

Moses, M., Huang, X., Xue, X., & Chen, C. (2025) · iScience · doi:10.1016/j.isci.2025.114091 · Cited by 13 · see citing works

Innate cells and STAT1-dependent signals orchestrate vaccine-induced protection against invasive Cryptococcus infection

Wang, K., Espinosa, V., Wang, Y., Lemenze, A. D., Kumamoto, Y., Xue, C., & Rivera, A. (2024) · mBio · doi:10.1128/mbio.01944-24 · Cited by 11 · see citing works

Development of a Heat-Killed fbp1 Mutant Strain as a Therapeutic Agent To Treat Invasive Cryptococcus Infection

Wang, Y., Wang, K., Rivera, A., & Xue, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04955-22 · Cited by 11 · see citing works

A Cryptococcus neoformans polysaccharide conjugate vaccine made with filtered polysaccharide elicits protective immunity in mice

Stempinski, P. R., Irizarry, P. R., McConnell, S. A., Lopes, L. C. L., Santos, S. R. D., Wear, M. P., & Casadevall, A. (2025) · Fungal Biology · doi:10.1016/j.funbio.2025.101544 · Cited by 12 · see citing works

Adjuvant Curdlan Contributes to Immunization against Cryptococcus gattii Infection in a Mouse Strain-Specific Manner

Brito, P. K. M. O., de Campos, G. Y., Guimarães, J. G., da Costa, L. S., de Moura, E. S., Chica, J. E. L., Roque‐Barreira, M. C., & da Silva, T. A. (2022) · Vaccines · doi:10.3390/vaccines10040620 · Cited by 9 · see citing works

Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi

Wang, Z., & Shao, J. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04010-7 · Cited by 9 · see citing works

Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of Cryptococcus neoformans var. grubii

Elhassan, R. M., Alsony, N. M., Othman, K. M., Izz-Aldin, D. T., Alhaj, T. A., Ali, A. A., Abashir, L. A., Ahmed, O. H., & Hassan, M. A. (2021) · Journal of Immunology Research · doi:10.1155/2021/9921620 · Cited by 13 · see citing works

The Sweet Side of Fungal Infections: Structural Glycan Diversity and Its Importance for Pathogenic Adaptation

Diniz-Lima, I., da Fonseca, L. M., dos Reis, J. S., Santos, M. A. R. D. C., da Costa, K. M., Santos, C. A. D. N., Barcelos, P. M., Pinto, K. G., Filardy, A. A., de Lima, M. E. F., et al. (2022) · Medicines · doi:10.3390/medicines9060037 · Cited by 8 · see citing works

Inhibition of host 5-lipoxygenase reduces overexuberant inflammatory responses and mortality associated with Cryptococcus meningoencephalitis

Castro-Lopez, N., Campuzano, A., Mdalel, E., Vanegas, D., Chaturvedi, A. K., Nguyen, P. M., Pulse, M., Cardona, A. E., & Wormley, F. L. (2024) · mBio · doi:10.1128/mbio.01483-24 · Cited by 7 · see citing works

Cryptococcus neoformans infections: aspartyl protease potential to improve outcome in susceptible hosts

Vernel-Pauillac, F., Laurent‐Winter, C., Fiette, L., Janbon, G., Aimanianda, V., & Dromer, F. (2024) · mBio · doi:10.1128/mbio.02733-24 · Cited by 7 · see citing works

Promising whole‐cell vaccines against cryptococcosis

Ueno, K., Tsuge, S., Shimizu, K., & Miyazaki, Y. (2023) · Microbiology and Immunology · doi:10.1111/1348-0421.13056 · Cited by 6 · see citing works

Dendritic Cells: Multifunctional Roles in Host Defenses to Cryptococcus Infections

Goughenour, K. D., Nair, A. S., Xu, J., Olszewski, M. A., & Wozniak, K. L. (2023) · Journal of Fungi · doi:10.3390/jof9111050 · Cited by 6 · see citing works

Design of a cryptococcus neoformans vaccine by subtractive proteomics combined with immunoinformatics

Zhu, F., Zhou, Z., Ma, S., Xu, Y., Tan, C., Yang, H., Zhang, P., Qin, R., Luo, Y., Pinhua, P., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112242 · Cited by 5 · see citing works

Immunoinformatic-guided designing and evaluating protein and mRNA-based vaccines against Cryptococcus neoformans for immunocompromised patients

Elalouf, A., & Yaniv-Rosenfeld, A. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00560-3 · Cited by 5 · see citing works

Computational vaccinology approach: Designing an efficient multi-epitope peptide vaccine against Cryptococcus neoformans var. grubii’s heat shock 70KDa proteinPreprint

Elhassan, R. M., Alsony, N. M., Othman, K. M., Izz-Aldin, D. T., Alhaj, T. A., Ali, A. A., Abashir, L. A., Ahmed, O. H., & Hassan, M. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/534008 · Cited by 5 · see citing works

A comprehensive immunoinformatic analysis of chitin deacetylase’s and MP88 for designing multi-epitope vaccines against Cryptococcus neoformans

Khan, M. A. S., Miah, M. I., & Rahman, S. R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2258410 · Cited by 4 · see citing works

Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines

Specht, C. A., Lam, W. C., Hester, M. M., Lourenço, D., Levitz, S. M., Lodge, J. K., & Upadhya, R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3722-7_27 · Cited by 4 · see citing works

Adjuvant ArtinM favored the host immunity against Cryptococcus gattii infection in C57BL/6 mice

Brito, P. K. M. O., de Campos, G. Y., Guimarães, J. G., Machado, M. P., da Costa, L. S., Chica, J. E. L., Roque‐Barreira, M. C., & da Silva, T. A. (2024) · Immunotherapy · doi:10.1080/1750743x.2024.2360384 · Cited by 3 · see citing works

Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections

Kulkarni, N. A., & Nanjappa, S. G. (2024) · Vaccines · doi:10.3390/vaccines12090981 · Cited by 3 · see citing works

Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains

Xue, X., Zang, X., Xiao, M., Wang, L., Wu, H., Ma, X., Wu, N., Deng, H., Zhou, M., Pan, L., et al. (2022) · Medical Mycology · doi:10.1093/mmy/myac035 · Cited by 3 · see citing works

Glycans of the Pathogenic Yeast Cryptococcus neoformans and Related Opportunities for Therapeutic Advances

Loza, L., & Doering, T. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00079-1 · Cited by 2 · see citing works

Insights from Mass Spectrometry-Based Proteomics on Cryptococcus neoformans

Betancourt, J. J., & Nielsen, K. (2025) · Journal of Fungi · doi:10.3390/jof11070529 · Cited by 2 · see citing works

mGem: Progress on the development of conjugate vaccines for Cryptococcus neoformans infections

Stempinski, P. R., Santos, S. R. D., & Casadevall, A. (2026) · mBio · doi:10.1128/mbio.03538-25 · Cited by 2 · see citing works

A consensus structural motif for the capsular polysaccharide of Cryptococcus Neoformans by NMR/MD

Prestegard, J. H. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2322413121 · Cited by 2 · see citing works

Exploring therapeutic targets for cryptococcosis: in silico and in vitro testing for isocitrate lyase (ICL1) potential inhibitors

Xavier, G. A., da Cruz, E. C., de Oliveira, R. S., da Silva, S. H. M., & Siqueira, A. S. (2025) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-025-00722-0 · Cited by 1 · see citing works

Synthetic glucuronoxylomannans enable molecular insights into antibody structure-function and fungal capsule architecturePreprint

Crawford, C. J., Guazzelli, L., McConnell, S. A., McCabe, O., d’Errico, C., Greengo, S. D., Wear, M. P., Jedlicka, A. J., Casadevall, A., & Oscarson, S. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-nm09n · Cited by 1 · see citing works

Macrophage-mediated innate immunity for the treatment of cryptococcal meningitis

He, Z. (2020) · AIP conference proceedings · doi:10.1063/5.0000307

Opportunistic Pathogens of the Genus Cryptococcus in Louis Pasteur Days and in 200th Anniversary of his Birth

Dyląg, M. (2022) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2022-025

Development of a heat-killed fbp1 mutant strain as a therapeutic agent to treat invasive Cryptococcus infectionPreprint

Wang, Y., Wang, K., Rivera, A., & Xue, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519380

Semi-synthetic glycoconjugate vaccine candidate against Cryptococcus neoformansPreprint

Crawford, C. J., Liporagi-Lopes, L. C., Coelho, C., dos Santos, S. R., Nicola, A. M., Wear, M. P., Vij, R., Oscarson, S., & Casadevall, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.02.578725

Criptococose como problema de saúde pública no Distrito Federal

Perazzoni, A. R. D. G., Guimarães, G. V. C., & Silva, R. A. E. (2024) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2022.9557

Design of Cryptococcus neoformans multi-epitope vaccine based on immunoinformatics method

Zhou, Z., Zhu, F., Ma, S., Tan, C., Yang, H., Zhang, P., Xu, Y., Qin, R., Luo, Y., Chen, J., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae080 · Cited by 1 · see citing works

Cryptococcusantigens and immune responses: implications for a vaccine

Chaturvedi, A. K., & Wormley, F. L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.840094 · Cited by 17 · see citing works

Host populations, challenges, and commercialization of cryptococcal vaccines

Poeta, M. D., Wormley, F. L., & Lin, X. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011115 · Cited by 40 · see citing works

Vaccine and Immunotherapeutic Approaches for the Prevention of Cryptococcosis: Lessons Learned from Animal Models

Hole, C. R., & Wormley, F. L. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00291 · Cited by 35 · see citing works

Prospects of vaccines for medically important fungi Feasibility and prospects for a vaccine to prevent cryptococcosis

Casadevall, A., & Pirofski, L. (2005) · Medical Mycology · doi:10.1080/13693780500448230 · Cited by 33 · see citing works

Vaccine Strategies for Cryptococcus neoformans

Brauer, V. S., Querobino, S. M., Matos, G. S., Dasilva, D., & Poeta, M. D. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3722-7_28